Summit Therapeutics, Inc. (SMMT)
16.63
-1.20
(-6.73%)
USD |
NASDAQ |
Nov 11, 16:00
16.63
0.00 (0.00%)
After-Hours: 16:13
Summit Therapeutics Total Return Level : 17.83 for Nov. 10, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 10, 2026 | 17.83 |
| November 09, 2026 | 17.84 |
| November 06, 2026 | 16.33 |
| November 05, 2026 | 14.19 |
| November 04, 2026 | 16.17 |
| November 03, 2026 | 15.80 |
| November 02, 2026 | 14.80 |
| October 30, 2026 | 16.03 |
| October 29, 2026 | 16.20 |
| October 28, 2026 | 15.77 |
| October 27, 2026 | 15.33 |
| October 26, 2026 | 14.50 |
| October 23, 2026 | 15.47 |
| October 22, 2026 | 15.55 |
| October 21, 2026 | 15.83 |
| October 20, 2026 | 16.09 |
| October 19, 2026 | 15.57 |
| October 16, 2026 | 14.63 |
| October 15, 2026 | 15.37 |
| October 14, 2026 | 15.13 |
| October 13, 2026 | 15.52 |
| October 12, 2026 | 17.13 |
| October 09, 2026 | 17.59 |
| October 08, 2026 | 17.17 |
| October 07, 2026 | 17.95 |
| Date | Value |
|---|---|
| October 06, 2026 | 17.31 |
| October 05, 2026 | 17.27 |
| October 02, 2026 | 16.76 |
| October 01, 2026 | 16.69 |
| September 30, 2026 | 16.91 |
| September 29, 2026 | 16.39 |
| September 28, 2026 | 15.48 |
| September 25, 2026 | 15.61 |
| September 24, 2026 | 16.38 |
| September 23, 2026 | 16.45 |
| September 22, 2026 | 17.12 |
| September 21, 2026 | 16.90 |
| September 18, 2026 | 17.85 |
| September 17, 2026 | 17.72 |
| September 16, 2026 | 17.30 |
| September 15, 2026 | 17.40 |
| September 14, 2026 | 18.42 |
| September 11, 2026 | 17.55 |
| September 10, 2026 | 17.00 |
| September 09, 2026 | 17.54 |
| September 08, 2026 | 17.28 |
| September 04, 2026 | 17.60 |
| September 03, 2026 | 17.13 |
| September 02, 2026 | 14.60 |
| September 01, 2026 | 14.16 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| NovelStem International Corp. | 0.0078 |
| Brainstorm Cell Therapeutics, Inc. | 0.9729 |
| Kezar Life Sciences, Inc. | 7.29 |
| Protara Therapeutics, Inc. | 2.43 |
| Clene, Inc. | 4.41 |